About 37.5 million people in the US have diabetes, with 96 million more with prediabetes2.
Within the diabetic population, diabetic retinopathy prevalence is estimated to be about 33%3 and is the leading cause of blindness in working age individuals in the US4. Due to the asymptomatic nature of this insidious disease, patients need to be screened regularly for evidence of diabetic retinopathy so that vision sparing treatment can be administered before long term damage occurs.